✦ LIBER ✦

BM-573, a thromboxane receptor antagonist, reduces development of atherosclerosis in apo E-deficient mice

✍ Scribed by C. Cherdon; S. Rolin; J. Hanson; P.V. Drion; L. de Leval; J.O. Defraigne; J.M. Dogné

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A novel thromboxane receptor antagonist

✍ Tillmann Cyrus; Yuemang Yao; Tao Ding; Jean Michel Dogné; Domenico Praticò 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 696 KB

BM-573 inhibits the development of early

✍ Céline Cherdon; Stéphanie Rolin; Julien Hanson; Annie Ooms; Laurence de Leval; P 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 586 KB

Tu-P7:47 Roles of thromboxane A2 and pro

✍ Kobayashi, T.; Oida, H.; Yurugi-Kobayashi, T.; Katagiri, H.; Majima, M.; Yokode, 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Helper-dependent adenoviral vector-media

✍ Lucio Pastore; L.Maria Belalcazar; Kazuhiro Oka; Racel Cela; Brendan Lee; Lawren 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 361 KB

Olmesartan, a novel angiotensin II type

✍ K. Shimada; T. Murayama; M. Yokode; T. Kita; M. Fujita; C. Kishimoto 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 418 KB

Bilberry anthocyanin-rich extract alters

✍ A. Mauray; C. Felgines; C. Morand; A. Mazur; A. Scalbert; D. Milenkovic 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 271 KB